SECH Albioma

Albioma : Availability of 2019 Universal Registration Document (French version)

Albioma : Availability of 2019 Universal Registration Document (French version)

Press release

Paris La Défense, 30 April 2020

Availability of 2019 Universal Registration Document (French version)

Albioma announces that the French version of its Universal Registration Document for the 2019 financial year has been made available to the public. It has been filed with the French Financial Market Authority (Autorité des Marchés Financiers) on 30 April 2020, under number D-20.0417.

The 2019 Universal Registration Document includes:

  • the Annual Financial Report for the 2019 financial year;
  • the report of the Board of Directors on corporate governance for the 2019 financial year;
  • the description of the share buy-back programme submitted for approval at the General Meeting of shareholders of 29 May 2020.

The Universal Registration Document may be consulted on Albioma’s website, (“Financial publications” tab) and is available upon simple request at the Company’s head office at the following address: Albioma, Company Secretariat, Tour Opus 12, 77 esplanade du Général de Gaulle, 92914 La Défense Cedex, France.

The English version of the Universal Registration Document shall be available shortly.

Next on the agenda: annual General Meeting of shareholders, on 29 May 2020 at 3 pm (CET).

About Albioma Contacts
An independent renewable energy producer, Albioma is committed to the energy transition thanks to biomass and photovoltaics.



The Group, which is established in Overseas France, Mauritius and Brazil, has developed a unique partnership for 25 years with the sugar industry, to produce renewable energy from bagasse, a fibrous residue from sugar cane.



Albioma is also the leading generator of photovoltaic power overseas where it constructs and operates innovative projects with integrated storage capabilities.
Investor

Julien Gauthier

+33 (0)1 47 76 67 00



Media

Charlotte Neuvy

+33 (0)1 47 76 66 65

   
Albioma shares are listed on EURONEXT PARIS (sub B) and eligible for the deferred settlement service (SRD) and PEA-PME plans (ISIN FR0000060402 – ticker: ABIO).



 

 

Attachment

EN
30/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Albioma

 PRESS RELEASE

Albioma : Press release relating to the squeeze-out procedure for the ...

Albioma : Press release relating to the squeeze-out procedure for the shares and warrants of Albioma PRESS RELEASE DATED SEPTEMBER 29, 2022 RELATING TO THE SQUEEZE-OUT PROCEDURE FOR THE SHARES AND WARRANTS OF ALBIOMA FOLLOWING THE PUBLIC TENDER OFFER INITIATED BY KYOTO BIDCO SAS AMOUNT OF INDEMNIFICATION: 50 euros per Albioma share (ex-dividend) 29,10 euros per Albioma Warrant This press release was prepared and distributed by Kyoto BidCo SAS in accordance with the provisions of Article 237-3 III of the General Regulation of the French Autorité des Marchés Fi...

 PRESS RELEASE

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire...

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire visant les actions et les BSAAR de la société Albioma Ce communiqué ne constitue pas une offre d’acquisition de titres. COMMUNIQUÉ DE PRESSE DU 29 SEPTEMBRE 2022RELATIF À LA MISE EN OEUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAAR DE LA SOCIÉTÉ ALBIOMACONSÉCUTIVEMENT À L’OFFRE PUBLIQUE D’ACHATINITIÉE PARKYOTO BIDCO SAS MONTANT DE L’INDEMNISATION : 50 euros par action Albioma (dividende détaché) 29,10 euros par bon de souscription et/ou d’acquisition d’actions remboursables Albioma Le présent communiqué...

Gaetan Calabro ... (+5)
  • Gaetan Calabro
  • Jeremy Sallee
  • Maxence Dhoury
  • Mohamed Kaabouni
  • Nicolas Royot

La Matinale - 2022-09-15

LA VALEUR DU JOUR : PRODWAYS : Des résultats semestriels exceptionnels / Contact – Acheter (1), obj. 4.00€ Cours: 3.28€ au 14/09/22 ALBIOMA : Vers un retrait de cote Cours: 47.1€ au 14/09/22 CARMAT : Confiant sur la reprise – Acheter (1), obj. 29.0€ Cours: 12.8€ au 14/09/22 ESKER : Un discours (trop?) prudent – Acheter (1), obj. 189.0€ Cours: 131.7€ au 14/09/22 INNATE PHARMA : Horizon de trésorerie confortable et de nouveaux projets à venir – Acheter (1), obj. 6.20€ Cours: 2.58€ au 14/09/22....

 PRESS RELEASE

Albioma : Success of the friendly Tender Offer initiated by KKR

Albioma : Success of the friendly Tender Offer initiated by KKR PRESS RELEASE Paris La Défense, 15 September 2022 Success of the friendly Tender Offer initiated by KKR KKR now holds 92.19% of Albioma’s capital Albioma and KKR announce the results of the friendly Tender Offer for all Albioma securities (the “Offer”) published by the Autorité des marchés financiers (“AMF”) following the closure of the second offer period on 9 September 2022. Following the closure of the second offer period initiated by KKR, 2.536.724 shares and 223 warrants (BSAAR) were tendered. Fol...

 PRESS RELEASE

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR s...

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma Communiqué de presse Paris La Défense, le 15 septembre 2022 Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma KKR détient désormais 92,19% du capital d’Albioma Albioma et KKR annoncent les résultats de l’Offre Publique d’Achat amicale sur l’ensemble des titres d’Albioma (l’« Offre ») publiés par l'Autorité des marchés financiers (« AMF ») à la suite de la clôture de l'Offre rouverte le 9 septembre 2022. A la suite de la clôture de l’Offre rouverte initiée par KK...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch